Mastering B-cell biomarker tracking in autoimmune therapy
Tuesday 11 November 2025
08:00 [PST] 11:00 [EST] 16:00 [GMT]
Empowering precision medicine: advanced B-cell profiling to guide personalized autoimmune therapies and validate immune reset strategies.
Join us for an in-depth webinar exploring a cutting-edge multiparametric flow cytometry assay designed to precisely monitor B-cell subsets implicated in autoimmune diseases. Discover how this high-throughput method enables the identification of pathogenic and regenerative B-cell populations, offering powerful insights into immune reset strategies and the clinical impact of personalized therapies. Ideal for immunologists, translational scientists and clinical researchers, this session will highlight novel biomarker opportunities and practical applications in guiding autoimmune disease management.
What will you learn?
-
Understand the role of B-cell subsets in autoimmune disease progression
-
Discover a novel multiparametric flow cytometry assay
-
Identify pathogenic and regenerative B-cell populations
-
Explore the concept of immune reset
-
Apply clinical utility in autoimmune disease management
Who may this interest?
-
Immunologists and autoimmune disease researchers
-
Clinical researchers and translational scientists
-
Flow cytometry specialists and lab technologists
-
Medical directors and clinical pathologists
-
Biomarker strategy teams
Amit Mehta
Senior Flow Design & Analyses Expert
Navigate BioPharma Services, Inc. (CA, USA)
Amit Mehta, earned his doctorate in Allergy & Immunology in India and completed a postdoctoral fellowship at the La Jolla Institute for Immunology (CA, USA), where he investigated the role of tumor necrosis factor superfamily members in airway inflammatory diseases. At Navigate BioPharma, a Novartis (Basel, Switzerland) subsidiary, Mehta plays a key role in assay development on the flow cytometry platform. His contributions span from panel design, high-dimensional data analysis, assay transfer for global clinical trials, to technical leadership in data interpretation. He also mentors team members and supports both core and cross-functional initiatives, driving innovation in clinical research and biomarker discovery.
In association with:
